Infarct size limitation by a new Na+-H+ exchange inhibitor, Hoe 642: Difference from preconditioning in the role of protein kinase C

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 693-701

  Miura, Tetsuji ^a   Ogawa, Takashi ^a   Suzuki, Katsuo ^a   Goto, Mahiko ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC AGENT; CARIPORIDE; PROTEINASE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION;

ANIMALS; GUANIDINES; HEART; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; POLYMYXIN B; PROTEIN KINASE C; RABBITS; SODIUM-HYDROGEN ANTIPORTER; SULFONES;

EID: 0031050219     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00522-0     Document Type: Article

References (52)

1. Miura T, Yellon DM, Hearse DJ, Downey JM. Determinants of infarct size during permanent occlusion of a coronary artery in the closed chest dog. J Am Coll Cardiol 1987;9:647-54.
2. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Comparison of unconscious and conscious dog model. Circ Res 1985;56:651-65.
3. Weaver WD. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 1995;25 Suppl:3S-9S.
4. Topol EJ. Thrombolytic intervention. In: Topol EJ, editor. Textbook of Interventional Cardiology. 2nd ed. Philadelphia: W.B. Saunders, 1994:68-111.
5. Cohen MV. Coronary Collaterals. Clinical and Experimental Observations. New York: Futura, 1985:93-185.
6. Miura T. Myocardial infarction. In: Sperelakis N, editor. Physiology and Pathophysiology of the Heart. 3rd ed. Norwell (MA): Kluwer, 1995:1125-45.
7. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029-42.
8. 2+ exchange. Circ Res 1989;65:1045-56.
9. + exchange. Am J Physiol 1988;255:H608-15.
10. Meng H-P, Pierce GN. Protective effects of 5-(N,N-dimethyl) amiloride on ischemia-reperfusion injury in hearts. Am J Physiol 1990;258:H1615-9.
11. Murphy E, Perlman M, London RE, Steenbergen C. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 1991;68:1250-8.
12. + exchange. Am J Physiol 1993;265:H2017-26.
13. Moffat MP, Karmazyn M. Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischemic contractile dysfunction in rat ant guinea pig hearts. J Mol Cell Cardiol 1993;25:959-71.
14. Meng H-P, Maddaford TG, Pierce GN. Effect of amiloride and selected analogues on postischemic recovery of cardiac contractile function. Am J Physiol 1993;264:H1831-5.
15. 2+ overload in isolated perfused rabbit heart. Circulation 1994;89:2787-98.
16. Myers ML, Mathur S, Li G-H, Karmazyn M. Sodium-hydrogen exchange inhibitors improve postischaemic recovery of function in the perfused rabbit heart. Cardiovasc Res 1995;29:209-14.
17. Kleyman TR, Cragoe EJ Jr. Amiloride and its analogs as tools in the study of ion transport. J Memb Biol 1988;105:1-21.
18. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation 1995;92:912-7.
19. Rohmann S, Weygandt H, Minck K-O. Preischaemic as well as postischaemic application of a Na/H exchange inhibitor reduces infarct size in pigs. Cardiovasc Res 1995;30:945-51.
20. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
21. Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993;72:44-9.
22. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993;27:617-22.
23. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 1994;28:1574-80.
24. Walsh RS, Tsuchida A, Daly JJF, Thornton JD, Cohen MV, Downey JM. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 1994;28:1337-41.
25. Miura T, Goto M, Sakamoto J, Shimamoto K, Iimura O. Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol 1995;25:531-8.
26. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
27. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 1995;29:682-8.
28. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27:883-92.
29. Hale SL, Kloner RA. Protection of myocardium by transient, preischemic administration of phenylephrine in the rabbit. Coron Artery Dis 1994;5:605-10.
30. Scholtz W, Albus U, Counillon L, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995;29:260-8.
31. Nachlas MM, Schnitka TK. Macroscopic identification of early myocardial infarction by alterations in dehydrogenase activity. Am J Pathol 1963;42: 379-405.
32. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992;26:456-61.
33. Kennedy RH, Berlin JR, Ng YC, Akera T, Brody TM. Amiloride: effect on myocardial force of contraction, sodium pump and Na/Ca exchange. J Mol Cell Cardiol 1986;18:177-88.
34. Gold MR, Strichartz GR. Use-dependent block of atrial sodium current by ethylisopropylamiloride. J Cardiovasc Pharmacol 1991;17:792-9.
35. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest 1988;82:920-7.
36. Hori M, Kitakaze M, Sato H, et al. Staged reperfusion attenuates myocardial stunning in dogs: role of transient acidosis during early reperfusion. Circulation 1991;84:2135-45.
37. Miura T, Downey JM, Ooiwa H, et al. Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J 1989;30:695-708.
38. 1 adenosine receptors in rabbit heart. Circulation 1991;84:350-6.
39. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 1992;86:979-85.
40. Wall TM, Sheely R, Harmtman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994;270:681-9.
41. Goto M, Liu Y, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77: 611-21.
42. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268: H2157-61.
43. Chen GL, Tang Y, Van Winkle DM. Stereospecific blockade of myocardial ischemic preconditioning by naloxone [abstract]. Circulation 1995;92 Suppl 1:1-389.
44. Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemie preconditioning in rabbit hearts [letter] Cardiovasc Drugs Ther 1994;8:881-2.
45. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 1995;268:H426-31.
46. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 1995;92:1546-57.
47. Vahlhaus C, Schultz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 1996;79:407-14.
48. 1-Adrenergic stimulation of Na-H exchange in cardiac myocytes. Am J Physiol 1992;263:C1096-1102.
49. Chang EB, Musch MW, Drabik-Arvans D, Rao MC. Phorbol ester inhibition of chicken intestinal brush-border sodium-proton exchange. Am J Physiol 1991;260:C1264-72.
50. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res 1993;72:112-25.
51. Ramasamy R, Liu H, Anderson S, Lundmark J, Schaefer S. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts. J Clin Invest 1995;96:1464-72.
52. Bugge E, Ytrehus K. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protective additive to ischaemic preconditioning. Cardiovasc Res 1995;29:269-74.